No Data
When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Turn A Profit?
S&P 500 Futures Rise In Premarket Trading; Workday, CAVA Group Lead
RNAi Market and Technologies Industry Report 2024, With Company Profiles of Major Players Including Alnylam Pharmaceuticals, Novartis, Thermo Fisher Scientific and Revvity
Alnylam Pharmaceuticals Insider Sold Shares Worth $4,200,000, According to a Recent SEC Filing
Alnylam Pharmaceuticals(ALNY.US) Officer Sells US$4.2 Million in Common Stock
Here's Why Alnylam Pharmaceuticals (ALNY) Surged in Q2